Sponsor pipeline

Guangdong Jianersheng Pharmaceutical Technology Co., Ltd. clinical trial pipeline

Get alerts when Guangdong Jianersheng Pharmaceutical Technology Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

First postedNew trial filingPhaseStatus
2026-09-17 NCT07824843 Safety Study of GMDTC Injection in Participants With Solid Tumors and Cisplatin-Induced… Phase 1 Not Yet Recruiting

Active trials by phase

Phase 1
1
Phase 2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT07057414 The Safety and Efficacy of GMDTC for Injection in Subjects With Elevated Cadmium Levels Cadmium Exceeds the Standard Recruiting 2025-09-02
Phase 1
NCT07824843 Safety Study of GMDTC Injection in Participants With Solid Tumors and Cisplatin-Induced… Cisplatin Nephrotoxicity Not Yet Recruiting 2026-09-17
Get alerts when Guangdong Jianersheng Pharmaceutical Technology Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free